Google Übersetzer
Genmab A/s
About
1,724.00DKK-10.50 -0.61%
Closed • Updated at 22:14 GMT+00:00Market Cap$16.08B
P/E Ratio20.17
Volume93.6K
Beta0.55
RSI50.57
Gross Margin93.31%
Genmab A/s — investor relations, events, news, and company updates on 6ix.
Latest News
May 8 2026
Major Shareholder Announcement
May 7 2026
Genmab Announces Financial Results for the First Quarter of 2026
Apr 17 2026
Genmab A/S Share Capital Reduction
Apr 14 2026
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026
Apr 13 2026
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer
Recent Videos
Cómo invertir en Genmab A/S (GMAB.CO) paso a paso
Apr 11, 2026
How to Invest in Genmab A/S -ADR (GMAB.US) Step by Step
Apr 10, 2026
Merus N.V. (MRUS) #Genmab #initialtenderoffer #SubsequentOfferingPeriod #deadline #petosemtamab
Dec 18, 2025
Genmab A/S 2025 R&D Update and ASH Data Review Meetin | Dec 11, 2025
Dec 12, 2025
Community Chat
Ask AI
Try asking